pgn-edodm1
pgn-edodm1: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| PepGen Inc. (PEPG) | Phase 2 |
Clinical Trials (1)
An Open-Label Extension Study Evaluating Safety and Pharmacokinetics in Participants With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
Frequently asked questions
Who is developing pgn-edodm1?
pgn-edodm1 is being developed by PepGen Inc..
How many clinical trials involve pgn-edodm1?
BioSniper tracks 1 clinical trial involving pgn-edodm1.
Get deeper analysis on pgn-edodm1
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis